SYMBIOTIC CAPITAL

symbiotic-capital-logo

Symbiotic Capital operates as a life science credit firm.

#SimilarOrganizations #Financial #More

SYMBIOTIC CAPITAL

Social Links:

Founded:
2022-01-01

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible HSTS Cloudflare JS CDN JS OpenResty Typekit


Similar Organizations

avalon-bioventures-logo

Avalon BioVentures

Avalon BioVentures operates as a biotech venture capital firm.

awesome-people-ventures-logo

Awesome People Ventures

Awesome People Ventures operates as a ventures capital firm.

fulton-labs-logo

Fulton Labs

Fulton Labs operates as a life and health sciences campus.

ivy-asset-group-logo

Ivy Asset Group

Ivy Asset Group operates as an alternative structured credit firm.

keystone-capital-corp-logo

Keystone Capital Corp.

Keystone Capital Corp. operates as a financial-services firm.

not_available_image

Ordinary Ventures

Ordinary Ventures operates as a ventures capital firm.

ssi-strategy-logo

SSI Strategy

SSI Strategy operates as a life sciences consultancy.

not_available_image

United Life Insurance Co.

United Life Insurance Co. operates as a life insurance provider.

Investments List

Date Company Article Money raised
2024-08-15 Caresyntax Symbiotic Capital investment in Series C - Caresyntax 80 M USD
2024-01-18 Accelus Symbiotic Capital investment in Debt Financing - Accelus 20 M USD

More informations about "Symbiotic Capital"

Symbiotic Capital - Life Science Credit

LIFE SCIENCE CREDIT For Science, By Science . 10100 SANTA MONICA BLVD. | FLOOR 15 LOS ANGELES, CASee details»

Symbiotic Capital - Crunchbase Investor Profile

Symbiotic Capital operates as a life science credit firm. Symbiotic Capital invests in late-stage and debt financing for healthcare, medical, and analytics industries, focusing on North America, particularly in Boston and Palm Beach Gardens. โ€ฆSee details»

Symbiotic Capital Management Co. LLC

September 2022 by Symbiotic Capital, LLC. Symbiotic Capital is a -firstof-its-kind life science credit platform and aspires to be the preferred credit partner for innovative life science โ€ฆSee details»

Symbiotic Capital, a First-of-its-Kind Life Science Credit Firm ...

Aug 6, 2024 Symbiotic Capital is affiliated with Bellco Capital ("Bellco"), the Los Angeles-based investment firm founded by biotechnology entrepreneur Dr. Arie Belldegrun. Symbiotic will โ€ฆSee details»

Inside Arie Belldegrunโ€™s $600M life sciences credit firm Symbiotic โ€ฆ

Aug 8, 2024 Backed by more than $600 million in committed capital, Symbiotic is designed to provide credit solutions and loans to established life ... Belldegrun will serve as co-chairman of โ€ฆSee details»

Biotech mogul Arie Belldegrun extends empire with โ€ฆ

Aug 6, 2024 On Tuesday, Belledegrun and his team announced they have raised more than $600 million for a new life science credit firm called Symbiotic Capital. Symbiotic said it will provide loans to biotechs ...See details»

Symbiotic Capital - LinkedIn

Symbiotic Capital is a life science credit firm, which aspires to be the preferred credit partner to the life science industry. We are bringing together expertise across life sciences, finance ...See details»

Symbiotic Capital, a First-of-its-Kind Life Science Credit Firm ...

Aug 6, 2024 Symbiotic Capital ("Symbiotic"), a global life science credit firm, was officially unveiled today with more than $600 million in capital committed and targeted for investments โ€ฆSee details»

Symbiotic Capitalโ€™s Himani Bhalla on creditโ€™s rising role in life ...

Sep 11, 2024 Catherine Longworth: Tell us about the genesis of Symbiotic Capital. Himani Bhalla: Symbiotic is a new credit platform that brings together experts from the life science โ€ฆSee details»

Symbiotic Capital Has $600 Million to Lend

Aug 12, 2024 Symbiotic Capital, a non-bank lender co-founded by local biotech magnate Arie Belldegrun, launched last week with more than $600 million in capital raised. 59.8 F. Los โ€ฆSee details»

Life science credit company Symbiotic Capital launches with $600m

Aug 7, 2024 New life science credit company Symbiotic Capital has launched with a fund of more than $600m for life science-specific loans. Co-chaired by veteran biotech entrepreneur โ€ฆSee details»

Life science credit firm unveils with $600M - Fierce Biotech

Aug 6, 2024 A new global life science credit firm, dubbed Symbiotic Capital, has raised more than $600 million. Symbiotic will deliver credit solutions to companies across biotech, โ€ฆSee details»

Biotech entrepreneur Arie Belldegrun launches new โ€˜science-first ...

Aug 6, 2024 Dive Brief: Arie Belldegrun, the founder of Allogene Therapeutics and Kite Pharma, unveiled a new credit firm Tuesday with $600 million to put to work providing loans to โ€ฆSee details»

Biopharma, finance vets launch $600m life sciences loan firm

Aug 6, 2024 Symbiotic Capital - which starts life with more than $600 million at its disposal - is an affiliate of Bellco Capital, an investment form set up by Arie Belldegrun, a biotech โ€ฆSee details»

Symbiotic Capital Company Profile: Financings & Team - PitchBook

Symbiotic Capital total number of employees/professionals is 6. What service provider type is Symbiotic Capital? Symbiotic Capital's service provider type is Lender. Data Transparency. โ€ฆSee details»

Symbiotic Capital - Investments, Portfolio & Company Exits

Aug 15, 2024 Symbiotic Capital has made 2 investments. Their most recent investment was on Aug 15, 2024, when Caresyntax raised. obfuscated. obfuscated. How many investments has โ€ฆSee details»

Symbiotic Capital Life Science Credit Fund - PitchBook

Symbiotic Capital Life Science Credit Fund is a credit special situations fund managed by Symbiotic Capital. The fund is located in Los Angeles, California. The fund targets to invest in โ€ฆSee details»

Symbiotic Capital Management

Symbiotic Capital Management is part of Fusion Group, a diversified group of financial companies with nearly $2bn under management and advice. We focus on niche alpha strategies and โ€ฆSee details»

Caresyntax Raises $180 Million Funding to Accelerate Growth and ...

Aug 15, 2024 The capital is being used for scaling customer adoption of surgical software tools and for continued development of the companyโ€™s AI and edge-to-cloud applications. The round โ€ฆSee details»

Randy Gacek - New York City Metropolitan Area

Principal & Co-Founder at Symbiotic Capital · Experience: Perceptive Advisors · Education: Rutgers University · Location: New York City Metropolitan Area · 500+ connections on LinkedIn.See details»

linkstock.net © 2022. All rights reserved